Results 21 to 30 of about 2,515,873 (332)

Modelling Bi-specific Antibodies in Aqueous Solution [PDF]

open access: yesarXiv, 2023
This study presents theoretical results for physico-chemical properties of system of molecules modeling bi-specific antibodies, such as, dual-variable-domain monoclonal antibodies (DVD-Ig) and Fabs-In-Tandem Immunoglobulin (FIT-Ig). These molecules are representatives of the engineered proteins that combine the function and specificity of two ...
arxiv  

The therapeutic monoclonal antibody market

open access: yesmAbs, 2015
Since the commercialization of the first therapeutic monoclonal antibody product in 1986, this class of biopharmaceutical products has grown significantly so that, as of November 10, 2014, forty-seven monoclonal antibody products have been approved in ...
D. Ecker, S. D. Jones, H. Levine
semanticscholar   +1 more source

Inhibition of neurite outgrowth in differentiating mouse N2a neuroblastoma cells by phenyl saligenin phosphate: Effects on MAP kinase (ERK 1/2) activation, neurofilament heavy chain phosphorylation and neuropathy target esterase activity [PDF]

open access: yes, 2006
Sub-lethal concentrations of the organophosphate phenyl saligenin phosphate (PSP) inhibited the outgrowth of axon-like processes in differentiating mouse N2a neuroblastoma cells (IC50 2.5 μM).
Abou-Donia   +56 more
core   +1 more source

Monoclonal Antibodies

open access: yesDermatologic Clinics, 2015
Use of monoclonal antibodies (mAbs) has revolutionized cancer therapy. Approaches targeting specific cellular targets on the malignant cells and in tumor microenvironment have been proved to be successful in hematologic malignancies, including cutaneous lymphomas.
openaire   +2 more sources

CHARACTERIZATION AND APPLICATION OF WDSSB5 MONOCLONAL ANTIBODY FOR THE DETECTION OF DENGUE VIRUS IN C6/36 CELL LINE USING IMMUNOCYTOCHEMICAL METHOD [PDF]

open access: yes, 2016
Introducition: Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are caused by Dengue virus that consists of 4 serotypes of Dengue Virus (DENV) 1, 2, 3 and 4.
Amarta, Wayan T   +2 more
core   +2 more sources

How mRNA therapeutics are entering the monoclonal antibody field

open access: yesJournal of Translational Medicine, 2019
In 1975, Milstein and Köhler revolutionized the medical world with the development of the hybridoma technique to produce monoclonal antibodies. Since then, monoclonal antibodies have entered almost every branch of biomedical research.
Lien Van Hoecke, K. Roose
semanticscholar   +1 more source

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys [PDF]

open access: yes, 2013
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with extraordinary potency and breadth have recently been described. In humanized mice, combinations of monoclonal antibodies have been shown to suppress viraemia, but the ...
Barouch, Dan H.   +25 more
core   +3 more sources

Behaviour of the model antibody fluid constrained by rigid spherical obstacles. Effects of the obstacle--antibody attraction [PDF]

open access: yesarXiv, 2021
This study is concerned with behaviour of fluid of monoclonal antibodies (mAbs) when trapped in a confinement represented by rigid spherical obstacles that attract proteins. The antibody molecule is depicted as an assembly of seven hard spheres, organized to resemble Y shaped molecule.
arxiv  

Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans [PDF]

open access: yes, 2013
Rabies kills many people throughout the developing world every year. The murine monoclonal antibody (mAb) 62-71-3 was recently identified for its potential application in rabies postexposure prophylaxis (PEP).
Anthony R. Fooks   +42 more
core   +1 more source

Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development

open access: yesClinical and Translational Science, 2018
The tutorial introduces the readers to the fundamentals of antibody pharmacokinetics (PK) in the context of drug development. Topics covered include an overview of antibody development, PK characteristics, and the application of antibody PK ...
Meric A. Ovacik, Kedan Lin
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy